High Growth Tech Stocks To Watch In September 2024

In This Article:

The market has climbed 2.6% in the last 7 days and is up 31% over the last 12 months, with earnings forecast to grow by 15% annually. In this thriving environment, identifying high-growth tech stocks that align with these robust conditions can be crucial for investors looking to capitalize on future opportunities.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

TG Therapeutics

28.39%

43.54%

★★★★★★

Super Micro Computer

20.81%

27.98%

★★★★★★

Sarepta Therapeutics

23.58%

44.12%

★★★★★★

Invivyd

42.91%

70.39%

★★★★★★

Ardelyx

27.46%

66.34%

★★★★★★

Amicus Therapeutics

20.32%

62.37%

★★★★★★

Clene

71.89%

60.05%

★★★★★★

Travere Therapeutics

26.68%

68.80%

★★★★★★

Seagen

22.57%

71.80%

★★★★★★

ImmunoGen

26.00%

45.85%

★★★★★★

Click here to see the full list of 248 stocks from our US High Growth Tech and AI Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

BeiGene

Simply Wall St Growth Rating: ★★★★☆☆

Overview: BeiGene, Ltd. is an oncology company focused on discovering and developing cancer treatments for patients globally, with a market cap of $20.97 billion.

Operations: BeiGene, Ltd. engages in the discovery and development of cancer treatments, generating $3.10 billion from pharmaceutical products across the United States, China, Europe, and other international markets.

BeiGene, navigating through a challenging landscape with a net loss reduction from $729.57 million to $371.56 million year-over-year, is showing signs of resilience despite being unprofitable. The company's R&D commitment is evident in its substantial investment in TEVIMBRA®, which has been approved across multiple regions for various cancer treatments, highlighting its strategic focus on global oncology leadership. With an expected revenue growth of 19.3% per annum outpacing the US market average of 8.7%, BeiGene's strategy to expand into lucrative markets and enhance its product offerings through rigorous trials could position it favorably for future profitability, forecasted to materialize within three years with earnings potentially growing by 64.1% annually.

NasdaqGS:BGNE Earnings and Revenue Growth as at Sep 2024
NasdaqGS:BGNE Earnings and Revenue Growth as at Sep 2024

Lumentum Holdings

Simply Wall St Growth Rating: ★★★★★☆

Overview: Lumentum Holdings Inc. manufactures and sells optical and photonic products across the Americas, the Asia-Pacific, Europe, the Middle East, and Africa with a market cap of $3.96 billion.

Operations: Lumentum Holdings Inc. generates revenue primarily from its Industrial Tech ($274.30 million) and Cloud & Networking ($1.08 billion) segments, focusing on optical and photonic products across multiple regions. The company's gross profit margin is a key financial metric to consider when evaluating its performance in these markets.